Two uninvestigated nuclear markers, Wilms’ Tumor 1 antigen (WT1) [34] and thymine dimers (TDs) [35], have recently shown potential relevance in the RCC clinical context. This evidence concerns the gene WT1 and renal cell carcinoma.